nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—CYP2C9—cardial valve—dilated cardiomyopathy	0.125	0.543	CbGeAlD
Zileuton—LTB4R—heart—dilated cardiomyopathy	0.0357	0.155	CbGeAlD
Zileuton—ALOX5—Synthesis of 5-eicosatetraenoic acids—GPX1—dilated cardiomyopathy	0.0332	0.102	CbGpPWpGaD
Zileuton—EPHX2—heart—dilated cardiomyopathy	0.0263	0.114	CbGeAlD
Zileuton—ALOX5—heart—dilated cardiomyopathy	0.0157	0.0682	CbGeAlD
Zileuton—Neck pain—Lisinopril—dilated cardiomyopathy	0.0141	0.0316	CcSEcCtD
Zileuton—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0138	0.0311	CcSEcCtD
Zileuton—Malaise—Spironolactone—dilated cardiomyopathy	0.0134	0.0302	CcSEcCtD
Zileuton—Discomfort—Spironolactone—dilated cardiomyopathy	0.0125	0.0282	CcSEcCtD
Zileuton—Hypertonia—Lisinopril—dilated cardiomyopathy	0.0122	0.0274	CcSEcCtD
Zileuton—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.0117	0.0262	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0114	0.035	CbGpPWpGaD
Zileuton—EPHX2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0109	0.0337	CbGpPWpGaD
Zileuton—Somnolence—Spironolactone—dilated cardiomyopathy	0.0108	0.0243	CcSEcCtD
Zileuton—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0105	0.0236	CcSEcCtD
Zileuton—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.01	0.0225	CcSEcCtD
Zileuton—Urticaria—Spironolactone—dilated cardiomyopathy	0.00966	0.0217	CcSEcCtD
Zileuton—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00961	0.0216	CcSEcCtD
Zileuton—PTGS1—myocardium—dilated cardiomyopathy	0.00905	0.0392	CbGeAlD
Zileuton—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00896	0.0201	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.00892	0.0275	CbGpPWpGaD
Zileuton—Pruritus—Spironolactone—dilated cardiomyopathy	0.0086	0.0193	CcSEcCtD
Zileuton—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00832	0.0187	CcSEcCtD
Zileuton—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00811	0.0182	CcSEcCtD
Zileuton—Dizziness—Spironolactone—dilated cardiomyopathy	0.00804	0.0181	CcSEcCtD
Zileuton—Flatulence—Furosemide—dilated cardiomyopathy	0.00799	0.0179	CcSEcCtD
Zileuton—Vomiting—Spironolactone—dilated cardiomyopathy	0.00773	0.0174	CcSEcCtD
Zileuton—Rash—Spironolactone—dilated cardiomyopathy	0.00767	0.0172	CcSEcCtD
Zileuton—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00766	0.0172	CcSEcCtD
Zileuton—Headache—Spironolactone—dilated cardiomyopathy	0.00762	0.0171	CcSEcCtD
Zileuton—Jaundice—Lisinopril—dilated cardiomyopathy	0.00759	0.017	CcSEcCtD
Zileuton—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00757	0.017	CcSEcCtD
Zileuton—UGT1A9—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.00746	0.023	CbGpPWpGaD
Zileuton—Sinusitis—Lisinopril—dilated cardiomyopathy	0.0073	0.0164	CcSEcCtD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.0073	0.0225	CbGpPWpGaD
Zileuton—Nausea—Spironolactone—dilated cardiomyopathy	0.00722	0.0162	CcSEcCtD
Zileuton—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00699	0.0157	CcSEcCtD
Zileuton—CYP2C9—heart—dilated cardiomyopathy	0.00692	0.03	CbGeAlD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00677	0.0209	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.00663	0.0204	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00636	0.0196	CbGpPWpGaD
Zileuton—PTGS1—heart—dilated cardiomyopathy	0.00632	0.0274	CbGeAlD
Zileuton—ALOX5—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00609	0.0188	CbGpPWpGaD
Zileuton—Flatulence—Lisinopril—dilated cardiomyopathy	0.00599	0.0135	CcSEcCtD
Zileuton—Tension—Lisinopril—dilated cardiomyopathy	0.00597	0.0134	CcSEcCtD
Zileuton—Nervousness—Lisinopril—dilated cardiomyopathy	0.00591	0.0133	CcSEcCtD
Zileuton—Somnolence—Furosemide—dilated cardiomyopathy	0.00588	0.0132	CcSEcCtD
Zileuton—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00571	0.0128	CcSEcCtD
Zileuton—Pain—Furosemide—dilated cardiomyopathy	0.00566	0.0127	CcSEcCtD
Zileuton—Constipation—Furosemide—dilated cardiomyopathy	0.00566	0.0127	CcSEcCtD
Zileuton—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00564	0.0127	CcSEcCtD
Zileuton—Malaise—Lisinopril—dilated cardiomyopathy	0.00549	0.0123	CcSEcCtD
Zileuton—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00545	0.0122	CcSEcCtD
Zileuton—PTGS1—cardiac atrium—dilated cardiomyopathy	0.0054	0.0234	CbGeAlD
Zileuton—Urticaria—Furosemide—dilated cardiomyopathy	0.00526	0.0118	CcSEcCtD
Zileuton—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00523	0.0118	CcSEcCtD
Zileuton—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00518	0.0116	CcSEcCtD
Zileuton—Chest pain—Lisinopril—dilated cardiomyopathy	0.00518	0.0116	CcSEcCtD
Zileuton—Myalgia—Lisinopril—dilated cardiomyopathy	0.00518	0.0116	CcSEcCtD
Zileuton—Discomfort—Lisinopril—dilated cardiomyopathy	0.00512	0.0115	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.00505	0.0156	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.00503	0.0155	CbGpPWpGaD
Zileuton—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00487	0.011	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00477	0.0147	CbGpPWpGaD
Zileuton—LTB4R—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00475	0.0146	CbGpPWpGaD
Zileuton—Pruritus—Furosemide—dilated cardiomyopathy	0.00468	0.0105	CcSEcCtD
Zileuton—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00453	0.0102	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00452	0.0102	CcSEcCtD
Zileuton—Insomnia—Lisinopril—dilated cardiomyopathy	0.00449	0.0101	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00443	0.0137	CbGpPWpGaD
Zileuton—Somnolence—Lisinopril—dilated cardiomyopathy	0.00441	0.00991	CcSEcCtD
Zileuton—Dizziness—Furosemide—dilated cardiomyopathy	0.00438	0.00983	CcSEcCtD
Zileuton—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00437	0.00982	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00429	0.0132	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00429	0.00963	CcSEcCtD
Zileuton—Pain—Lisinopril—dilated cardiomyopathy	0.00425	0.00954	CcSEcCtD
Zileuton—Constipation—Lisinopril—dilated cardiomyopathy	0.00425	0.00954	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00424	0.0131	CbGpPWpGaD
Zileuton—Vomiting—Furosemide—dilated cardiomyopathy	0.00421	0.00945	CcSEcCtD
Zileuton—Rash—Furosemide—dilated cardiomyopathy	0.00417	0.00937	CcSEcCtD
Zileuton—Dermatitis—Furosemide—dilated cardiomyopathy	0.00417	0.00936	CcSEcCtD
Zileuton—Headache—Furosemide—dilated cardiomyopathy	0.00415	0.00931	CcSEcCtD
Zileuton—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00409	0.00919	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00409	0.0126	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00409	0.0126	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00406	0.0125	CbGpPWpGaD
Zileuton—Urticaria—Lisinopril—dilated cardiomyopathy	0.00394	0.00886	CcSEcCtD
Zileuton—Nausea—Furosemide—dilated cardiomyopathy	0.00393	0.00883	CcSEcCtD
Zileuton—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00392	0.00882	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00387	0.0119	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0038	0.0117	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00377	0.0116	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00368	0.0114	CbGpPWpGaD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00367	0.0113	CbGpPWpGaD
Zileuton—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00366	0.00822	CcSEcCtD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00354	0.0109	CbGpPWpGaD
Zileuton—Pruritus—Lisinopril—dilated cardiomyopathy	0.00351	0.00789	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00348	0.0107	CbGpPWpGaD
Zileuton—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.0034	0.00763	CcSEcCtD
Zileuton—LTB4R—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00334	0.0103	CbGpPWpGaD
Zileuton—Dizziness—Lisinopril—dilated cardiomyopathy	0.00328	0.00738	CcSEcCtD
Zileuton—Vomiting—Lisinopril—dilated cardiomyopathy	0.00316	0.00709	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00314	0.00969	CbGpPWpGaD
Zileuton—Rash—Lisinopril—dilated cardiomyopathy	0.00313	0.00703	CcSEcCtD
Zileuton—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00313	0.00703	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00311	0.0096	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00311	0.0096	CbGpPWpGaD
Zileuton—Headache—Lisinopril—dilated cardiomyopathy	0.00311	0.00699	CcSEcCtD
Zileuton—EPHX2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00301	0.0093	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00299	0.00921	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00298	0.0092	CbGpPWpGaD
Zileuton—Nausea—Lisinopril—dilated cardiomyopathy	0.00295	0.00662	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00289	0.00893	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—TAZ—dilated cardiomyopathy	0.00283	0.00874	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0028	0.00864	CbGpPWpGaD
Zileuton—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00267	0.00825	CbGpPWpGaD
Zileuton—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00264	0.00814	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—SDHA—dilated cardiomyopathy	0.00256	0.00791	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00239	0.00738	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.0023	0.00709	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00227	0.00701	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00227	0.007	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00221	0.00682	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.00219	0.00675	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00207	0.00639	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.002	0.00618	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00188	0.00581	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00176	0.00543	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00176	0.00543	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00176	0.00543	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00168	0.00519	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00168	0.00518	CbGpPWpGaD
Zileuton—UGT1A9—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.00168	0.00517	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ANKRD1—dilated cardiomyopathy	0.00168	0.00517	CbGpPWpGaD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.00164	0.00506	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00164	0.00504	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00163	0.00504	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.0016	0.00493	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.0016	0.00493	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00158	0.00488	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—TAZ—dilated cardiomyopathy	0.00158	0.00486	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00156	0.00482	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00154	0.00475	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00153	0.00474	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00152	0.0047	CbGpPWpGaD
Zileuton—UGT1A9—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.00151	0.00466	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00148	0.00458	CbGpPWpGaD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.00148	0.00456	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.00144	0.00445	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00144	0.00444	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—SDHA—dilated cardiomyopathy	0.00143	0.0044	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00142	0.00438	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00139	0.00428	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00138	0.00424	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00137	0.00423	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00135	0.00417	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00128	0.00396	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00123	0.00381	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00123	0.00379	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00119	0.00366	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00117	0.00359	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00113	0.00349	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00106	0.00328	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00102	0.00314	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000996	0.00307	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000952	0.00294	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000943	0.00291	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000943	0.00291	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000905	0.00279	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000892	0.00275	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000877	0.00271	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00087	0.00268	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000864	0.00267	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000858	0.00265	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000849	0.00262	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000847	0.00261	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—TAZ—dilated cardiomyopathy	0.000839	0.00259	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000807	0.00249	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000771	0.00238	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000763	0.00235	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	0.000758	0.00234	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000733	0.00226	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000727	0.00224	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000725	0.00224	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GPX1—dilated cardiomyopathy	0.000696	0.00215	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00069	0.00213	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000688	0.00212	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000684	0.00211	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—CD36—dilated cardiomyopathy	0.000678	0.00209	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000667	0.00206	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000618	0.00191	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AGT—dilated cardiomyopathy	0.000611	0.00188	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.0006	0.00185	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000591	0.00182	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000534	0.00165	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000529	0.00163	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000529	0.00163	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—AGT—dilated cardiomyopathy	0.000511	0.00157	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000504	0.00155	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000504	0.00155	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000463	0.00143	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000451	0.00139	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000411	0.00127	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000406	0.00125	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GPX1—dilated cardiomyopathy	0.000387	0.00119	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000382	0.00118	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—CD36—dilated cardiomyopathy	0.000377	0.00116	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000377	0.00116	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000367	0.00113	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000359	0.00111	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000354	0.00109	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AGT—dilated cardiomyopathy	0.00034	0.00105	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000331	0.00102	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000327	0.00101	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000325	0.001	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000307	0.000947	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000278	0.000857	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000252	0.000778	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000243	0.000749	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000237	0.000731	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000214	0.000661	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	0.000206	0.000636	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	0.000201	0.000619	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000198	0.000612	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000193	0.000596	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	0.000181	0.000557	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000174	0.000536	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000169	0.000523	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	0.000168	0.000518	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000165	0.000509	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—CD36—dilated cardiomyopathy	0.000164	0.000505	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000149	0.000458	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AGT—dilated cardiomyopathy	0.000147	0.000454	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	8.83e-05	0.000272	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	8.6e-05	0.000265	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	7.74e-05	0.000239	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	7.54e-05	0.000233	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	7.35e-05	0.000227	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	6.62e-05	0.000204	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.82e-05	0.00018	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.67e-05	0.000175	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.11e-05	0.000157	CbGpPWpGaD
